Viemed Healthcare, Inc. (VMD)
NASDAQ: VMD · Real-Time Price · USD
6.99
+0.13 (1.90%)
Nov 25, 2025, 11:09 AM EST - Market open
Viemed Healthcare Revenue
Viemed Healthcare had revenue of $71.91M in the quarter ending September 30, 2025, with 23.98% growth. This brings the company's revenue in the last twelve months to $254.79M, up 18.90% year-over-year. In the year 2024, Viemed Healthcare had annual revenue of $224.26M with 22.54% growth.
Revenue (ttm)
$254.79M
Revenue Growth
+18.90%
P/S Ratio
1.05
Revenue / Employee
$216,110
Employees
1,179
Market Cap
265.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 224.26M | 41.25M | 22.54% |
| Dec 31, 2023 | 183.01M | 44.18M | 31.82% |
| Dec 31, 2022 | 138.83M | 21.77M | 18.60% |
| Dec 31, 2021 | 117.06M | -14.25M | -10.85% |
| Dec 31, 2020 | 131.31M | 51.05M | 63.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
VMD News
- 17 days ago - Viemed Healthcare, Inc. (VMD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Viemed Healthcare Announces Third Quarter 2025 Financial Results - Accesswire
- 4 weeks ago - Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details - Accesswire
- 2 months ago - Viemed Healthcare Announces Completion of Share Repurchase Program - Accesswire
- 3 months ago - Viemed Healthcare, Inc. (VMD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Viemed Healthcare Announces Second Quarter 2025 Financial Results - Accesswire
- 4 months ago - Viemed Healthcare Announces Second Quarter 2025 Earnings Conference Call Details - Accesswire
- 5 months ago - Viemed Completes Acquisition of Lehan's Medical Equipment Anticipates Updating its Full Year 2025 Outlook for the Acquisition with Second Quarter 2025 Financial Results - Accesswire